In cryo-electron microscopy, purified molecules are suspended in a thin layer of liquid and rapidly frozen into a glass-like state known as vitreous ice. This preserves the sample without forming the damaging ice crystals produced by conventional freezing. Before vitrification, however, the protein solution must be spread across a very thin film. That process creates extensive contact between the molecules and the air–water interface, the boundary separating the liquid from the surrounding air. For many proteins, this interface is not chemically or physically neutral. Molecules may migrate toward it, partially unfold, become damaged or attach to the surface in ways that restrict their orientation.

The consequences can be severe for image processing. Cryo-electron microscopy reconstructs a three-dimensional structure by combining thousands or millions of two-dimensional particle images captured from different viewing angles. If a protein adopts only a narrow range of orientations, some surfaces may never be observed clearly. This phenomenon, known as preferred orientation, can leave gaps in the reconstruction and limit the final resolution. Uneven sample distribution can also reduce the number of usable particles, while molecular damage may produce a mixture of intact and altered structures that complicates classification. In effect, the air–water interface can introduce artifacts before the electron microscope even begins collecting data.

The researchers’ solution is to package target proteins inside highly hydrophilic protein shells. These shells are described as structurally homogeneous and stable, properties that are central to the method’s proposed protection mechanism. Rather than allowing the molecule of interest to interact directly with the air–water boundary, the nanocrate presents a more water-compatible exterior. The shell acts as a physical buffer around its cargo, potentially reducing disruptive interfacial contacts while keeping the target protein enclosed in a defined environment. Because the nanocrate itself is a protein structure, it can also serve as a recognizable component during particle imaging and computational analysis.

The concept is not simply to hide a protein inside a container, but to create a package compatible with the entire cryo-electron microscopy workflow. The researchers describe procedures for loading or “packaging” target proteins, acquiring images of the resulting particles and reconstructing their structures from those images. This integration is important because any protective enclosure must remain stable during sample preparation, withstand rapid freezing and preserve enough structural information about its cargo for reconstruction. The nanocrate must also be sufficiently consistent from particle to particle; otherwise, variations in the shell could make alignment and classification more difficult rather than easier.

To demonstrate the method, the team selected three proof-of-principle targets, each representing a different structural biology challenge. The first was apoferritin, a widely used benchmark for high-resolution cryo-electron microscopy. Its inclusion tests whether enclosing a protein in a nanocrate can still support detailed reconstruction rather than sacrificing resolution for protection. The second target was thyroglobulin, chosen because it has presented a known preferred-orientation problem. If nanocrate packaging changes how the molecule interacts with the air–water interface, it could broaden the distribution of views available for reconstruction. The third was 7,8-dihydroneopterin aldolase, a protein whose structure had not previously been characterized by cryo-electron microscopy, providing a test of whether the approach can open access to new targets.

Apoferritin serves as a particularly revealing experiment because high-resolution cryo-electron microscopy places stringent demands on every stage of the workflow. At that scale, small variations in particle integrity, motion, orientation and image quality can affect the quality of the final map. A successful nanocrate experiment with apoferritin therefore suggests that the shell can protect its cargo without preventing the collection of detailed structural information. The result is significant not because apoferritin itself is an unsolved biological mystery, but because it tests whether encapsulation is compatible with the precision expected from modern cryo-electron microscopy.

Thyroglobulin addresses a different and widespread problem. Large or asymmetric proteins can settle against the air–water interface in a limited set of poses, causing thousands of apparently useful images to contain nearly the same projection. Computational methods can sometimes compensate for this imbalance, but they cannot fully recover views that were never recorded. By surrounding thyroglobulin with a hydrophilic, stable shell, the researchers sought to alter the interfacial behavior of the entire particle. The experiment therefore examines whether a target that naturally tends to lie in preferred orientations can be presented to the microscope in a more diverse set of views, improving the completeness of the reconstruction.

The final demonstration, involving 7,8-dihydroneopterin aldolase, highlights the broader promise of the technology. Many proteins remain difficult to study because they are sensitive to interfaces, too small or unstable under conventional preparation conditions, or resistant to producing the varied particle views needed for a reliable map. Encapsulation could offer a general strategy for reducing one major source of sample-preparation stress. The method will still need to be evaluated across a wider range of proteins and experimental conditions, and the relationship between the nanocrate, its cargo and image-processing performance will be important to establish. Nevertheless, the three examples present a coherent case: by turning vulnerable proteins into protected composite particles, nanocrates may help cryo-electron microscopy move beyond the limitations imposed by the air–water interface.

Subject of Research: A cryo-electron microscopy sample-preparation method that encapsulates target proteins in hydrophilic, stable protein shells called nanocrates to reduce air–water interface-induced damage, uneven distribution and preferred orientation.

Article Title: Overcoming air–water interface-induced artifacts in cryo-EM with protein nanocrates

Article References: Jenkins, M.C., Bobe, D., Johnston, J.D. et al. Overcoming air–water interface-induced artifacts in cryo-EM with protein nanocrates. Nat Methods (2026). https://doi.org/10.1038/s41592-026-03184-w

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41592-026-03184-w

Keywords: cryo-electron microscopy, cryo-EM, air–water interface, protein nanocrates, preferred orientation, protein encapsulation, structural biology, apoferritin, thyroglobulin, 7,8-dihydroneopterin aldolase

At the heart of BL18U1’s innovation lies its finely tuned microbeam, which delivers a beam size of approximately 9.8 micrometers horizontally and 4.6 micrometers vertically at the sample stage. This precise beam geometry is meticulously optimized to address the diffraction requirements of protein microcrystals, membrane protein assemblies, and a spectrum of small-molecule crystals, many of which pose notable experimental challenges due to their diminutive size or inherent fragility. The beamline’s capacity to produce such a focused beam stems from an innovative optical design that ensures both stability and beam quality, critical factors underpinning reproducible, high-fidelity diffraction measurements.

The beamline operates within a versatile tunable energy window spanning from 5 to 18 keV. This energy flexibility empowers researchers to tailor experiments according to their specific scientific goals, encompassing conventional diffraction, absorption-edge spectroscopy, as well as specialized anomalous diffraction methods. Crucially, this adaptability enables the execution of experiments requiring precise energy selection such as multi-wavelength anomalous diffraction or sulfur-SAD phasing, which are indispensable for de novo structure determination particularly when heavy atom derivatives are unavailable.

Instrumental integration at BL18U1 epitomizes the fusion of cutting-edge hardware with sophisticated control systems. The MD2 microdiffractometer at the core of the experimental station offers ultra-precise crystal alignment, facilitating meticulous sample positioning at the micron and submicron scale. Complementing this is the Pilatus 3 6M detector, renowned for its rapid frame rates and high dynamic range, enabling rapid data acquisition without compromising the integrity of diffraction signals. The Rigaku ACTOR robotic sample changer markedly accelerates throughput by automating sample exchange, thereby minimizing downtime and enhancing reproducibility. Together with an advanced cryogenic cooling apparatus, these components converge to optimize experimental conditions, preserving crystal integrity throughout data collection phases.

The integration of the MXCuBE3 control software synergizes the hardware capabilities by providing an intuitive, streamlined interface for experiment management. This platform coordinates precise sample alignment, automated data collection sequences, and real-time feedback, enabling researchers to maximize efficiency and data quality with minimal manual intervention. The seamless operation of these integrated systems ensures that experimental workflows at BL18U1 are both robust and adaptable to a wide array of crystallographic inquiries.

Demonstrating its prowess, BL18U1 has routinely produced diffraction data of exceptional quality, pushing the boundaries of attainable resolution. Experiments using lysozyme crystals yielded diffraction patterns extending to a remarkable 1.28 Å resolution, with processing statistics underscoring excellent data completeness and signal-to-noise ratios. Such performance illustrates the beamline’s capacity to reveal atomic-level details critical for elucidating intricate biomolecular architectures, thereby enhancing the precision of subsequent structural modeling efforts.

Notably, BL18U1 excels in long-wavelength anomalous diffraction applications, with demonstrated capability at a wavelength of 2.02 Å. This feature is particularly significant for sulfur-SAD phasing, a method leveraging the intrinsic anomalous signals from endogenous sulfur atoms within proteins. The enhanced anomalous signals collected at BL18U1 facilitate reliable phase determination even in the absence of exogenous heavy atom labels, thus broadening the scope of structure determination for proteins that have historically evaded crystallographic characterization.

The impact of BL18U1 extends well beyond individual experiments, as evidenced by its substantial contribution to the Protein Data Bank (PDB). By the close of 2024, diffraction data collected at this beamline had been instrumental in the deposition of 1,687 macromolecular structures, predominantly within a high-resolution range between 1.5 and 2.5 Å. This impressive output underscores the beamline’s pivotal role in advancing the global structural biology community, enabling groundbreaking insights into protein function, enzymatic mechanisms, and drug-target interactions.

The transformative nature of BL18U1 is further amplified by its integrated approach that combines technical excellence with user-centric operational efficiency. Researchers benefit from a platform that streamlines the entire experimental lifecycle, from crystal mounting and alignment to data acquisition and initial processing. This holistic integration not only accelerates research timelines but also ensures reproducibility and methodological rigor, fostering an environment conducive to high-impact scientific discovery.

In addition to facilitating traditional crystallographic studies, BL18U1’s capabilities open new frontiers for analyzing complex biological systems that were previously intractable due to sample constraints. Microcrystals derived from membrane proteins and multi-protein assemblies often exhibit heterogeneity and limited size, challenges that BL18U1’s focused beam and sensitive detection systems are specifically designed to overcome. Through this, the beamline supports an expanding array of structural investigations, encompassing dynamic and functional states of biomolecules critical for biomedical innovation.

The strategic development of BL18U1 as part of the National Facility for Protein Science in Shanghai highlights China’s growing leadership in synchrotron-based research infrastructure. By providing a world-class experimental platform, SSRF not only bolsters domestic scientific capacity but also fosters international collaboration, enabling a diverse community of researchers to access cutting-edge tools for macromolecular crystallography. This fosters an inclusive scientific environment accelerating structural insights across a range of disciplines, from fundamental biology to pharmaceutical development.

Looking ahead, BL18U1’s integration of precision optics, advanced robotics, and adaptive software positions it as a cornerstone facility capable of meeting the evolving demands of structural biology. Its contributions to high-resolution diffraction, anomalous signal exploitation, and throughput efficiency demonstrate a model for next-generation synchrotron beamlines. As scientific questions grow increasingly complex, platforms like BL18U1 will remain indispensable for decoding the molecular machinery of life with unrivaled accuracy and speed.

Subject of Research: Not applicable
Article Title: The protein microcrystallography beamline (BL18U1) at the Shanghai Synchrotron Radiation Facility
News Publication Date: 18-Jun-2026
Web References: http://dx.doi.org/10.1007/s41365-026-01991-6
References: Nuclear Science and Techniques
Image Credits: Wen-Ming Qin
Keywords: Nuclear physics, Accelerator physics

Mitochondrial ribosomes, or mitoribosomes, are specialized ribosomal complexes responsible for translating mitochondrial mRNAs into proteins crucial for respiratory function and energy metabolism. While the bacterial and cytosolic ribosomal structures have been extensively studied, plant mitochondrial ribosomes have remained, until now, a largely uncharted territory given their unique RNA and protein composition distinct from their animal counterparts. Leveraging cryo-EM technology, Waltz, Soufari, Bochler, and colleagues have rendered the first high-resolution look at this essential nanomachine embedded within plant cells.

Cryo-EM, a method that flash-freezes biomolecules and images them at cryogenic temperatures, has revolutionized structural biology. This approach circumvents the need for crystallization—especially difficult for large, flexible complexes—and produces near-atomic resolution maps. Using this technique, the researchers captured the plant mitoribosome’s architecture with unprecedented clarity, revealing its RNA-rich cores and associated protein regions that assemble into a functional ribosome distinct from previously characterized mitochondrial ribosomes in animals and fungi.

One of the most striking features of the plant mitochondrial ribosome revealed by this structure is the unusually high RNA content. Unlike animal mitoribosomes that have comparatively diminished rRNA content, plant mitoribosomes retain extensive RNA expansion segments. These RNA elements are hypothesized to influence ribosomal stability, fidelity, and interaction with mitochondrial mRNAs, positing a divergent evolutionary path shaped by the unique bioenergetic and genetic demands of plant mitochondria.

Moreover, the study delineates the numerous ribosomal proteins that coexist with the RNA core, many of which are plant-specific or bear remarkable modifications indicative of adaptation to the plant mitochondrial environment. The interplay between RNA expansion segments and these protein components likely underpins specialized functions such as selective translation initiation and complex assembly/disassembly dynamics essential for mitochondrial regulation under varied metabolic states.

Understanding this ribosomal machinery is crucial, considering mitochondria’s role beyond ATP production. They participate in signaling pathways regulating growth, programmed cell death, and responses to biotic and abiotic stresses. As the plant mitochondrial ribosome orchestrates mitochondrial gene expression, insights into its structure illuminate the mechanisms dictating mitochondrial biogenesis and function, contributing to broader comprehension of plant resilience and productivity.

The study also sets a new benchmark for exploring ribosome heterogeneity within the plant kingdom. Given that ribosomes adapt to fulfill specialized roles—sometimes called “specialized ribosomes”—the detailed plant mitoribosome structure invites further research into how structural variations confer selective translational control. Such investigations could lead to manipulations of mitochondrial translation to enhance crop yield or tolerance to environmental challenges.

Importantly, the research provides a framework for understanding mitochondrial diseases and defects arising from impaired ribosomal function. Although most mitochondrial dysfunction research has focused on animals, plant mitochondrial pathologies, such as cytoplasmic male sterility influencing hybrid seed production, could now be dissected at the molecular level. The new structural insights pave the way for engineering ribosome-targeted interventions that modulate mitochondrial activity in plants to improve agricultural traits.

Technologically, the study exemplifies the power of cutting-edge cryo-EM combined with advanced computational methods to unravel complex macromolecular assemblies. Detailed models created from the data will serve as templates for comparative analyses and molecular docking studies, facilitating drug design and synthetic biology applications aiming to reprogram mitochondrial translation.

The authors emphasize the potential for the observed RNA structures to serve as novel interfaces for protein synthesis regulators, including translational activators and mitochondrial RNA-binding proteins. These findings underscore a sophisticated coordination network between the ribosome and mitochondrial gene expression machinery, possibly tailored by plants for rapid adaptation to fluctuating energy demands.

Beyond the mechanistic details, this high-resolution plant mitoribosome structure provides a valuable resource for evolutionary studies, illuminating how ribosomes have diversified and specialized across the tree of life. Such evolutionary insights deepen our grasp of fundamental biological processes and may inspire biomimetic designs in nanotechnology and synthetic biology.

While the current structure represents a major leap forward, researchers anticipate that studying the ribosome in various functional states—such as during translation initiation, elongation, and termination—will yield further mechanistic insights, revealing dynamic conformational changes and regulatory checkpoints unique to plant mitochondria.

This discovery offers an exciting vista onto the delicate balance life maintains between its nuclear and organellar genomes, with the mitoribosome at the heart of this relationship. As plants face mounting environmental changes, understanding this nexus will be crucial to unlocking strategies for sustainable agriculture and ecology in the future.

In sum, the elucidation of the RNA-rich plant mitochondrial ribosome structure by Waltz et al. stands as a paradigm-shifting achievement, answering longstanding questions about mitochondrial gene expression in plants and opening fertile ground for diverse scientific explorations. The implications resonate not only within fundamental biology but also in biotechnology, agriculture, and medicine.

As these molecular portraits continue to sharpen, the scientific community eagerly awaits the next chapters in mitoribosome research, fueled by this first detailed glimpse of the plant’s mitochondrial protein factory—an intricate molecular masterpiece fundamental to life’s endurance and flourishing.

Subject of Research: Structural characterization of the RNA-rich mitochondrial ribosome in plants using cryo-electron microscopy.

Article Title: Addendum: Cryo-EM structure of the RNA-rich plant mitochondrial ribosome.

Article References:
Waltz, F., Soufari, H., Bochler, A. et al. Addendum: Cryo-EM structure of the RNA-rich plant mitochondrial ribosome. Nat. Plants (2026). https://doi.org/10.1038/s41477-025-02209-0

Image Credits: AI Generated

Deep learning has proven to be a powerful tool in this research, as it requires substantially less user input compared to traditional design methods. This enhancement in usability not only democratizes access to advanced protein engineering but also stimulates creativity in the design process. By employing deep learning, the researchers were able to streamline the process of identifying compatible scaffolds that can accommodate complex epitopes, which is crucial for developing proteins that can perform multiple functions simultaneously.

One of the highlights of the study is the successful design of scaffolds that bind effectively to all three selected antibodies through a remarkably compact library of sequences. Unlike previous approaches that often necessitate extensive libraries and in vitro evolution techniques, this study achieved impressive results with a limited number of designed sequences. This efficiency in design marks a significant milestone in the evolution of protein engineering, shedding light on the potential for creating multifunctional designs with limited resources.

The use of RFjoint2 Inpainting exemplifies the innovative approaches taken in this study, allowing researchers to generate an array of topological solutions for multimotif scaffolding. This technique enables variations in relative motif orientations while maintaining a high degree of structural accuracy. As a result, local structural similarities to the native epitope structures were achieved, which is essential for maintaining functionality across all three epitopes displayed in novel folds that are dissimilar to existing structures in the Protein Data Bank (PDB).

The implications of this research extend beyond mere structural engineering. When applied as immunogens, the designed scaffolds display multiple epitopes on the surface, suggesting that such designs could significantly enhance antigenic presentations. The functionality of these multiepitope immunogens represents a double-edged sword; not only did they demonstrate improved reactivity in immunological assays, but they also outperformed traditional single-epitope counterparts in eliciting cross-reactive antibody titers. This is a critical advancement in the pursuit of more effective vaccines.

Interestingly, the findings reveal that priming an immune response with a multiepitope scaffold followed by a boost with an alternative multiepitope scaffold featuring the same grafted epitopes leads to a highly targeted immune response. This approach allows for the selective boosting of antibodies against desired epitopes, while also minimizing the production of antibodies that might recognize neoepitopes, a significant challenge in vaccine design.

Comparative analysis with previous methods highlights the efficiency of the newly designed multiepitope immunogen in generating a robust immune response. Researchers found that the multiepitope immunogens provided a superior means to mediate immune responses across a broader antigenic surface compared to traditional single-epitope designs. Highlighted within the study is the promising observation that one of the three-epitope immunogens displayed physiologically relevant neutralization titers, further indicating its potential utility as a therapeutic candidate.

In essence, this work could redefine the operational landscape for vaccine developers, particularly in the context of seasonal or pandemic viral threats. By consolidating the immunogenic properties of multiple epitopes into a single scaffold, researchers could greatly enhance the efficiency of vaccine production, reducing costs and expediting validation processes, which are vital in the fast-paced landscape of modern virology.

These innovative multiepitope designs not only stand out for their practicality but also for their superior ability to align with the natural antigenic surfaces of pathogens. By enhancing the proportion of desirable antigenic features while mitigating the chances of off-target antibody elicitation, the scaffolds designed by Castro and colleagues represent a remarkable step forward in synthetic biology.

Looking forward, the implications of this breakthrough are immense. The ability to design proteins that incorporate multiple functional sites can advance various applications, spanning from enzyme design to therapeutic interventions and biosensors. The bridge formed between structural novelty and functional capability exemplifies the potential of integration between generative deep learning and molecular biology, paving the way for future explorations in protein engineering.

As researchers continue to push the boundaries of design, this study serves as a compelling example of what can be achieved when innovation meets scientific inquiry. The accuracy and versatility of the results underscore how generative deep learning can provide tailored solutions to complex design challenges, making it an invaluable tool in the quest for multifunctional biomolecules.

Ultimately, the successful implementation of deep learning strategies in protein design highlights an exciting new chapter in the field, where the convergence of artificial intelligence and biotechnology can lead to remarkable enhancements in both research and therapeutic development. The potential for such technology to yield effective immunogens opens new avenues for addressing unresolved challenges in vaccine development, particularly amidst the ever-evolving landscape of infectious diseases.

The outcomes of this research could redefine not only how vaccines are formulated but also enhance our understanding of protein functionality and interaction, solidifying deep learning’s role as a central player in the future of molecular design.

Subject of Research: De novo protein design of multimotif scaffolds using deep learning techniques.

Article Title: Accurate single-domain scaffolding of three nonoverlapping protein epitopes using deep learning.

Article References:

Castro, K.M., Watson, J.L., Wang, J. et al. Accurate single-domain scaffolding of three nonoverlapping protein epitopes using deep learning.
Nat Chem Biol (2025). https://doi.org/10.1038/s41589-025-02083-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41589-025-02083-z

Keywords: Deep learning, protein design, multimotif scaffolding, immunogens, vaccine development

NBCn1 is known for its vital role in shuttling bicarbonate ions in concert with sodium ions across cellular membranes, effectively modulating intracellular pH. Its function influences numerous cellular activities such as metabolism, signal transduction, and ion channel regulation. Despite its importance, high-resolution structural information about NBCn1 has remained elusive, hindering the development of targeted therapies for conditions linked to dysfunctional pH regulation, including cancer, neurological disorders, and renal pathologies. This pioneering research fills that critical knowledge gap by revealing the transporter’s conformational landscapes and gating mechanisms at near-atomic detail.

The investigators employed CryoEM, a revolutionary technique capable of visualizing biomolecules in their native states without the need for crystallization, enabling the capture of NBCn1 crystal-clear images while immersed in a solution that mimics physiological conditions. By freezing the transporter swiftly in vitreous ice, the team preserved its functional conformations. The integration of computational modeling then allowed the refinement of structural data to manage regions less defined by raw microscopy, producing a complete and precise topological map of NBCn1’s membrane-embedded domains.

The elucidated structure highlights distinct features responsible for ion coordination and translocation. Notably, the study identifies a unique ion binding pocket formed by conserved amino acid residues meticulously arranged to facilitate the selective passage of bicarbonate while simultaneously co-transporting sodium ions. This dual-ion specificity is crucial for maintaining electroneutral transport, ensuring that the movement of ions across the membrane does not disrupt membrane potential – a fundamental principle for cellular homeostasis.

Moreover, the research delves into the dynamic conformational shifts NBCn1 undergoes to alternate between inward-facing and outward-facing states, a hallmark of secondary active transporters operating via an alternating access mechanism. The high-resolution snapshots depict a well-orchestrated series of domain movements, underscoring how the protein gates open and close cyclically to prevent ion backflow, thereby sustaining directional bicarbonate and sodium flux. These conformational insights offer a clearer understanding of how NBCn1 activity can be modulated allosterically or via post-translational modifications.

Intriguingly, the study also reveals a notable pH-sensitive regulatory motif embedded within the transporter’s architecture. This motif functions as an intrinsic sensor that influences NBCn1’s activity in response to shifts in the cellular or extracellular proton concentration, fine-tuning the transporter’s efficiency based on environmental cues. Deciphering this regulatory mechanism sheds light on the molecular basis of pH-dependent modulation, a feature that may prove critical in designing pharmaceutical agents that selectively alter NBCn1 function under pathological conditions.

This work stands out not only due to its technical prowess but also owing to the comprehensive computational simulations that complement the experimental data. Using molecular dynamics, the research team simulated the transport cycle over extended timescales, capturing transient intermediate states that evade experimental detection. These simulations helped contextualize experimental observations within a dynamic framework, increasingly essential for understanding membrane protein functions that transcend static snapshots.

The biomedical implications of these findings are immense. NBCn1 has been implicated in cancer cell proliferation and migration, where altered pH regulation confers a survival advantage in tumor microenvironments. By providing a structural blueprint, this study propels the development of custom-designed inhibitors or modulators that can specifically target NBCn1’s ion-binding or regulatory sites, potentially attenuating cancer progression. Furthermore, aberrations in NBCn1 function have been associated with neurological diseases characterized by dysregulated ion transport, suggesting broader clinical applications.

In addition to human health, the structural insights into NBCn1 extend to fundamental physiology. The transporter’s role in maintaining systemic acid-base balance was always acknowledged, but now, mechanistic details clarify how NBCn1 integrates with other ionic transporters to sustain cellular environments conducive to optimal enzyme activity and metabolic flux. Understanding these interactions on a molecular level also presents opportunities to investigate compensatory mechanisms that cells activate in response to NBCn1 dysfunction.

This seminal research exemplifies the symbiotic power of CryoEM and computational biology in membrane protein research. Historically challenging due to their hydrophobic nature and dynamic conformations, membrane proteins like NBCn1 are now accessible to atomic-level scrutiny. The methodologies employed here could be extrapolated to other SLC4 family members, facilitating comparative analyses that might unravel evolutionary conserved mechanisms or specialization tailored to distinct physiological niches.

Looking forward, the study invites further exploration into NBCn1’s interaction with cellular partners. Proteins rarely act in isolation, and NBCn1’s association with scaffolding proteins, kinases, or regulatory factors likely modulates its function within complex cellular milieus. Integrative structural biology approaches, such as CryoEM coupled with cross-linking mass spectrometry and live-cell imaging, could provide a holistic view of NBCn1 within its native interactome and functional assemblies.

Beyond the basic science, translational prospects loom large. The discoveries equip pharmaceutical developers with tangible structural templates for rational drug design campaigns, possibly enabling high-throughput screens of small molecules that bind unique conformational states of NBCn1. This approach heralds a new era of precision medicine targeting ion transporters previously deemed undruggable due to structural and dynamic complexity.

In conclusion, this research delivers a tour de force in molecular medicine by demystifying the structural basis of NBCn1’s pH regulating capabilities. As both a physiological cornerstone and a potential therapeutic target, understanding the detailed workings of NBCn1 furnishes the scientific community with a critical foundation to exploit for future health innovations. With advances like this, the once enigmatic landscape of membrane transporter biology is rapidly transforming, promising novel interventions against diseases rooted in fundamental ionic dysregulation.

Subject of Research: Structural and functional characterization of the pH regulator NBCn1 (sodium bicarbonate cotransporter) through CryoEM and computational modeling.

Article Title: CryoEM and computational modeling structural insights into the pH regulator NBCn1.

Article References:
Wang, W., R. Zhekova, H., Tsirulnikov, K. et al. CryoEM and computational modeling structural insights into the pH regulator NBCn1. Nat Commun 16, 9932 (2025). https://doi.org/10.1038/s41467-025-64868-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-025-64868-z

Repeat-expansion RNAs are notorious for their role in pathogenic conditions such as Huntington’s disease and certain forms of amyotrophic lateral sclerosis (ALS), where elongated nucleotide sequences cause abnormal RNA aggregation. These aggregates, often forming condensates through phase separation, disrupt cellular machinery and lead to disease phenotypes. Despite their critical importance, the transient and heterogeneous nature of these RNA condensates has long challenged traditional structural biology methods.

The study introduces a water-detected NMR strategy that circumvents these hurdles by exploiting the unique properties of water molecules intimately associated with RNA condensates. Unlike conventional NMR techniques that rely solely on direct detection of RNA nuclei, this method harnesses the dynamic exchange between water protons and RNA protons, dramatically enhancing sensitivity and temporal resolution. Such water-mediated detection allows researchers to observe RNA condensates in near-native environments, maintaining their dynamic states without inducing artifacts commonly caused by sample preparation.

Central to this technique is its ability to probe RNA molecules within condensed phases while preserving the delicate interplay of molecular interactions. Repeat-expanded RNAs typically undergo liquid-liquid phase separation (LLPS), resulting in dense, droplet-like structures that are challenging to characterize due to their dynamic and often transient nature. By detecting water signals that interact with these RNA repeats, the method provides a window into the fleeting conformations and intermolecular contacts that govern condensate formation and dissolution.

The implications of this approach extend far beyond methodological advancement. Understanding the dynamics of repeat-expansion RNA condensates in physiological and pathological contexts could yield vital clues about disease mechanisms. For instance, the aberrant aggregation of these RNAs within neurons is thought to sequester crucial RNA-binding proteins, disturbing gene regulation and cellular homeostasis. Through real-time monitoring of condensate dynamics, this water-detected NMR method could illuminate how molecular interactions fluctuate during disease progression or in response to therapeutic interventions.

Moreover, the technique’s adaptability means it could be applied to a broad spectrum of RNA and RNA-protein condensates. Many cellular processes—such as stress granule formation, RNA transport, and translation control—depend on the ability of RNAs to form and dissolve biomolecular condensates. Capturing the transient structural states of these assemblies could lead to new insights into cellular regulation and the etiology of diseases involving dysfunctional condensate dynamics.

The team behind this advancement, led by experts Schmoll, Novakovic, and Allain, meticulously optimized the experimental parameters to balance sensitivity and resolution. By fine-tuning the exchange rates between water and RNA protons, they achieved a delicate equilibrium that allows for detailed observation without perturbing the condensate environment. This methodological finesse ensures that the data reflect authentic molecular behavior rather than artifacts introduced by measurement techniques.

Another remarkable aspect of this work is its contribution to the broader field of phase separation biology. The concept that cellular components can organize via LLPS has transformed our understanding of intracellular compartmentalization. However, many fundamental questions remain about how transient interactions at the molecular level translate into the mesoscale properties of condensates. Water-detected NMR offers a tool to bridge this gap by providing molecular-level insights into dynamics that underlie phase transitions.

This method also potentially opens new avenues in drug discovery and therapeutic monitoring. Small molecules that modulate the formation or stability of RNA condensates are emerging as promising candidates for treating neurological disorders related to repeat expansions. By providing dynamic, real-time data on RNA-condensate interactions, researchers can better assess how candidate compounds influence condensate properties, shape RNA conformations, and alter interaction networks within these dense droplets.

Given the method’s reliance on water dynamics, it also provides information on hydration shells and the role of water molecules in stabilizing or destabilizing condensate structures. Water is more than a passive solvent; it actively participates in biomolecular recognition and assembly. Elucidating these hydration dynamics adds a new dimension to our understanding of RNA condensates and may reveal mechanisms by which environmental factors or cellular stress conditions impact condensate behavior.

Crucially, this work demonstrates the feasibility of observing complex biological systems in near-physiological conditions, a long-standing goal in structural biology. Many techniques require non-physiological buffers, high temperatures, or dehydration that can alter native structures. By using a water-detected approach, studies can maintain physiological salt and pH levels, preserving biological relevance while still acquiring high-resolution dynamic data.

As the biological community continues to explore the versatile roles of RNA beyond simple gene expression templates, methods like water-detected NMR will be essential to elucidate the structural underpinnings of RNA’s regulatory functions. The dynamic assembly of repeat-expansion RNA condensates represents a frontier in this exploration, where structural transitions correlate closely with cellular health or disease states.

Future applications of this technique may extend to living cells, where in-cell NMR could integrate water detection to monitor intracellular RNA condensates in their native environments. Such development would dramatically enhance our ability to study RNA dynamics under physiologically relevant conditions and in response to environmental or pharmacological stimuli.

Taken together, the introduction of water-detected NMR as a tool for investigating repeat-expansion RNA condensates marks a significant milestone in molecular biology. It combines technical innovation with biological relevance, providing a powerful approach to capture the elusive, dynamic behaviors of RNA assemblies implicated in health and disease.

The insights gained from this study promise to deepen our comprehension of RNA-driven phase separation phenomena and their regulation, potentially leading to novel therapeutic strategies. By illuminating the subtle choreography of molecules within RNA condensates, researchers can better understand the molecular basis of neurologic disorders, cellular stress responses, and RNA-mediated regulation, thereby opening new frontiers in both basic and translational science.

Subject of Research: Repeat-expansion RNA condensates and their dynamic behavior.

Article Title: Water-detected NMR allows dynamic observations of repeat-expansion RNA condensates.

Article References:
Schmoll, J., Novakovic, M. & Allain, F.H.. Water-detected NMR allows dynamic observations of repeat-expansion RNA condensates. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01968-9

Image Credits: AI Generated

A cornerstone of this transformation is the legacy of AlphaFold, a revolutionary AI model developed by Google DeepMind that accurately predicts the three-dimensional structures of proteins based on amino acid sequences. Enabled by extensive open data shared by EMBL-EBI and global collaborators, AlphaFold has catalyzed a paradigm shift in structural biology, ensuring that protein structure predictions are freely accessible to researchers worldwide. This accomplishment underscores EMBL’s critical role as a facilitator and innovator in the AI life sciences ecosystem.

Expanding beyond structural biology, EMBL is pioneering novel AI-driven methodologies that apply to diverse biological datasets. Leveraging machine learning for cellular imaging allows for enhanced resolution and throughput beyond traditional microscopy techniques, reducing reliance on manual image analysis and improving experimental consistency. Furthermore, the integration of heterogeneous biological datasets—such as genomics, proteomics, and metabolomics—is enabling a systems-level understanding of biological processes, facilitating biomarker discovery and disease characterization with unprecedented precision.

Central to EMBL’s AI vision is the transformational funding from the German Hector Foundation, which has committed long-term support earmarked for building dedicated AI research groups, advancing data engineering capabilities, and deploying state-of-the-art computational infrastructure. This philanthropic investment not only provides the resources necessary for sustained innovation but also supports fellowship programs designed to cultivate multidisciplinary expertise that bridges computational and biological sciences—ensuring a pipeline of talent equipped to tackle tomorrow’s scientific challenges.

Oliver Stegle, EMBL’s Acting Head of AI, emphasizes that the true power of AI is realized through collaborative, cross-disciplinary efforts spanning geographical and institutional boundaries. AI’s ability to rapidly process massive biological datasets — ranging from genomic sequences to clinical health records — enables hypothesis generation and experimental design at scales and speeds unattainable by traditional methods. However, meaningful breakthroughs emerge from synergistic partnerships that integrate domain expertise and computational innovation.

EMBL envisions the future of life sciences research as inherently interdisciplinary. Machine learning models deployed for decoding genomic complexity continue to evolve, harnessing long-read sequencing technologies to uncover structural variants and somatic mutations critical in cancer genomics. Concurrently, AI methods enrich proteomics by predicting protein structures and dynamic interactions, contributing to a nuanced understanding of cellular machinery and pathophysiology. These advances offer promising avenues for precision medicine and therapeutic development.

In cellular microscopy, AI-driven image analysis algorithms improve the resolution and quantitative interpretation of cellular and subcellular structures. Automating traditionally laborious processes reduces human bias and enhances reproducibility, facilitating large-scale experiments that chart developmental pathways or disease progression. This shift from manual curation to computational inference supports high-throughput phenotyping and accelerates biological discovery.

Drug discovery is undergoing a radical transformation through AI-powered molecular simulations. These methods integrate physics-based models with machine learning to predict molecular interactions and prioritize pharmacological targets efficiently. By significantly compressing research timelines and resource requirements, AI accelerates the path from molecular hypothesis to viable drug candidates, enhancing lead optimization and toxicity prediction with increasing accuracy.

The sheer volume and diversity of biological data necessitate sophisticated data management systems to ensure accessibility and interoperability. EMBL’s AI-guided platforms improve data annotation, curation, and synthesis, fostering open science and enabling researchers to navigate vast datasets effectively. This democratization of data resources facilitates a global research community working collaboratively and building on shared knowledge.

Anna Kreshuk, senior scientist at EMBL, reflects that artificial intelligence is not merely a tool but is fundamentally reshaping the scientific process. AI influences how research questions are formulated, strategies are devised, and experiments are integrated with computational models. This paradigm shift brings together theoretical insights and empirical evidence in a tighter dialogue, accelerating iterative cycles of hypothesis testing and validation.

To fully leverage AI’s transformative potential, EMBL is intensifying efforts to create a pan-European AI ecosystem through strategic partnerships with academic institutions, industry stakeholders, and policy makers. By assembling a critical mass of expertise, resources, and infrastructure, EMBL fosters an environment of rigorous, open, and collaborative science. Training initiatives ensure that emerging scientists develop the computational literacy and interdisciplinary skills required to lead in this evolving landscape.

Ethical considerations are integral to EMBL’s AI strategy, addressing privacy, reproducibility, and societal impact. Responsible AI deployment ensures that advances in computational biology contribute positively, maintaining transparency and trustworthiness in scientific outputs. EMBL’s leadership extends beyond technology, promoting frameworks that guide the ethical conduct of AI-driven research aligned with societal values.

The Hector Foundation’s visionary philanthropy catalyzes EMBL’s capacity for sustained leadership at the interface of AI and life sciences. This investment not only amplifies EMBL’s innovative research programs but also creates momentum for attracting additional funding and forging collaborative networks across Europe. Dr. h.c. Hans-Werner Hector emphasizes that AI represents a new scientific epoch, one in which computational ingenuity drives breakthroughs that benefit medicine, research, and society holistically.

Together, EMBL’s strategic vision, scientific excellence, and collaborative ethos establish a global benchmark for AI-integrated life science research. By empowering researchers with advanced computational tools, multidisciplinary expertise, and ethical rigor, EMBL accelerates the pace of discovery and fosters innovations that transcend disciplinary and geographic boundaries. The integration of AI into the fabric of biological research heralds an era of unprecedented insight into life’s fundamental mechanisms and transformative applications for human health.

Subject of Research: Artificial Intelligence Integration in Life Sciences Research at EMBL
Article Title: EMBL’s Visionary AI Strategy: Revolutionizing Life Sciences Through Advanced Computational Research
News Publication Date: Not explicitly provided
Web References:

• https://www.embl.org/topics/ai-at-embl/
• https://www.embl.org/news/science/alphafold-using-open-data-and-ai-to-discover-the-3d-protein-universe/
• https://www.embl.org/editorhub/wp-content/uploads/2025/02/EMBL_AI-Strategy_Feb2025_Accessible.pdf
• https://www.ebi.ac.uk/about/news/perspectives/leveraging-long-read-sequencing-for-cancer-genomics/
• https://www.embl.org/news/science/puzzling-out-the-structure-of-a-molecular-giant/
• https://www.embl.org/news/science/charting-a-multi-omic-universe/
• https://www.embl.org/news/science-technology/follow-the-cellular-road/
• https://www.embl.org/news/science/machine-learning-to-identify-and-prioritise-drug-targets/
• https://www.embl.org/news/science/ai-annotations-increase-patent-data-in-surechembl/
  Image Credits: Creative team/ EMBL
  Keywords: Life sciences

In the realm of muscle contraction and cellular motility, myosin has long been recognized as a powerful motor protein. The mechanism by which it travels along actin filaments, primarily driven by ATP hydrolysis, is not only fundamental but also compelling. Studies have sequentially elucidated the structural transitions from unbound primed myosin to primed actomyosin and finally to the post-power stroke states. Each transition mirrors minute yet significant alterations in both the myosin and actin structures that facilitate this incredible force-generating capacity.

For instance, the preliminary weak binding of primed myosin to actin underlines a vital aspect of this interaction—the electrostatic complementarity between the positively charged residues of myosin’s loop 2 and the negatively charged residues in actin subdomain 1. This binding step is crucial as it positions the myosin lever arm in close proximity to the actin filament. These initial interactions trigger subsequent conformational changes within the myosin structure, setting the stage for force production.

As myosin engages actin, the interplay between the hydrophobic and ionic interactions leads to greater stabilization of the myosin’s light chain domain, referred to as L50. This stabilization is pivotal as it transitions myosin to the primed actomyosin state, characterized by a cocked position of the upper 50-kDa domain. The delicate balance of mechanical strain and molecular stabilization highlights the sophisticated choreography that occurs at the molecular level.

The transition from primed to the post-power stroke (postPS) state unveils the underlying principle of cleft closure in myosin. This mechanism is critically linked to the hydrolysis of ATP and results in a strong-binding interface necessary for enduring force production. As myosin experiences the lever swing, the transducer and relay helix undergo substantial reshaping, ultimately leading to the power stroke—a kinetic phenomenon observed in real-time through advanced imaging techniques.

Delving deeper into the mechanism of ATPase activation, one can observe how the N-terminal residues of actin play a crucial role. These residues become ordered upon binding with myosin, a structural change that significantly enhances actin’s ability to activate myosin’s ATPase activity. This rearrangement underscores the interdependence of myosin and actin as they engage in a dynamic partnership, critical for cellular movement.

Moreover, it is essential to highlight that while the actin structure remains relatively conserved through its various states, the motions of the N-terminal residues reveal a remarkable plasticity. This adaptability is central to the coordination required for efficient ATP hydrolysis and subsequent dissociation of inorganic phosphate (P_i). The rigorous timing of these events contributes to the overall efficiency of the power stroke.

The disassociation of P_i, a vital step catalyzed by the mechanical strain imparted by myosin actin binding, is a critical point of focus. The intricate dynamics showcase how myosin releases P_i in a carefully orchestrated fashion, illustrating the advantages of the energy economy present in cellular processes. This delay in phosphate release provides insights into how kinetic parameters govern the interaction dynamics, allowing for a seamless transition during muscle contraction.

Interestingly, the presence of an axial load introduces a layer of complexity in myosin’s functionality. Despite external resistance, myosin remains effectively coupled between cleft closure and lever swing, an observation that speaks to the motor protein’s ability to maintain its grip on actin filaments. Such resilience ensures that the force output remains consistent, underscoring how molecular mechanics operate with precision even under stress.

Fascinatingly, the serendipitous nature of these biochemical interactions illustrates a broader principle in molecular biology—the concept of cooperative binding. Both myosin and actin exemplify how slight changes in conformation can lead to significant functional outputs, a principle that resonates throughout numerous biological pathways.

The study of the myosin-actin interaction not only expands our comprehension of muscle physiology but also offers potential avenues in biotechnology and medicine. Understanding this mechanism can inspire new interventions in muscular disorders and provide groundwork for bioengineering applications where actin-myosin systems could be manipulated for desired outcomes.

Ultimately, the observations gleaned from this research provide a glimpse into the future of molecular biology and the vast potential for discovering novel therapeutic strategies and building synthetic biological systems. As our understanding of these molecular machines continues to evolve, we find ourselves at the threshold of groundbreaking discoveries that could transform how we approach biological function and disease.

By demystifying the mechanics underlying myosin and actin interactions, researchers are paving the way for innovations that promise to enhance our capabilities in various fields, from regenerative medicine to robotics. The journey of exploring these molecular interactions is just beginning, inviting further inquiry and exploration into the life-sustaining rhythms of cells.

In conclusion, myosin’s mechanism of movement, facilitated by actin catalysis, reflects the intricate balance of molecular forces that drive cellular dynamics. The continuous interplay between structure and function illustrates a profound aspect of life at the nanoscale, embodying the elegance and complexity that define biological systems. As we unravel these molecular mysteries, the impact of our discoveries holds the potential to redefine the interface between biology and technology, inspiring a new generation of scientists in their quest to understand and apply the wonders of life.

Subject of Research: Myosin and Actin Interactions in Muscle Contraction

Article Title: Swinging lever mechanism of myosin directly shown by time-resolved cryo-EM

Article References:
Klebl, D.P., McMillan, S.N., Risi, C. et al. Swinging lever mechanism of myosin directly shown by time-resolved cryo-EM. Nature (2025). https://doi.org/10.1038/s41586-025-08876-5

Image Credits: AI Generated

DOI: 10.1038/s41586-025-08876-5

Keywords: Myosin, actin, ATPase activation, muscle contraction, cryo-EM, molecular mechanics, cell motility, structural biology.